LifeVantage (LFVN) Stock Forecast, Price & News

LifeVantage's stock was trading at $3.72 on January 1st, 2023. Since then, LFVN stock has increased by 26.9% and is now trading at $4.72.
View the best growth stocks for 2023 here.

LifeVantage saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 39,900 shares, an increase of 19.1% from the April 30th total of 33,500 shares. Based on an average daily volume of 17,700 shares, the days-to-cover ratio is currently 2.3 days. Currently, 0.4% of the company's shares are sold short.
View LifeVantage's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 22nd 2023.
View our LFVN earnings forecast.

LifeVantage Co. (NASDAQ:LFVN) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.21 by $0.02. The company earned $53.22 million during the quarter. LifeVantage had a positive trailing twelve-month return on equity of 3.32% and a negative net margin of 0.40%. During the same period in the previous year, the company posted $0.25 earnings per share.

LifeVantage declared a quarterly dividend on Thursday, April 27th. Investors of record on Thursday, June 1st will be given a dividend of $0.035 per share on Thursday, June 15th. This represents a $0.14 annualized dividend and a yield of 2.97%. The ex-dividend date of this dividend is Wednesday, May 31st. This is a boost from the stock's previous quarterly dividend of $0.03.
Read our dividend analysis for LFVN.

LifeVantage (NASDAQ:LFVN) pays an annual dividend of $0.14 per share and currently has a dividend yield of 2.61%.
Read our dividend analysis for LFVN.

5 employees have rated LifeVantage Chief Executive Officer Darren Jensen on Glassdoor.com. Darren Jensen has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other LifeVantage investors own include Cleveland-Cliffs (CLF), Acer Therapeutics (ACER), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA), Enphase Energy (ENPH), NewAge (NBEV), Catalyst Biosciences (CBIO), Chesapeake Energy (CHKAQ) and ConocoPhillips (COP).

LifeVantage trades on the NASDAQ under the ticker symbol "LFVN."

LifeVantage's stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (6.61%), Dimensional Fund Advisors LP (1.74%), Globeflex Capital L P (0.33%), Susquehanna International Group LLP (0.24%), Tower Research Capital LLC TRC (0.09%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Darren Jay Jensen, Darwin Lewis, Garry Paul Mauro, Justin Rose and Michael A Beindorff.
View institutional ownership trends.

Shares of LFVN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LFVN stock can currently be purchased for approximately $4.72.

LifeVantage (NASDAQ:LFVN) has a market capitalization of $60.39 million and generates $210.12 million in revenue each year. The company earns $3.12 million in net income (profit) each year or ($0.06) on an earnings per share basis.

The company employs 263 workers across the globe.

LifeVantage's mailing address is 9785 S. MONROE STREET SUITE 400, SANDY UT, 84070. The official website for the company is www.lifevantage.com. The company can be reached via phone at (801) 432-9000, via email at scott.vanwinkle@icrinc.com, or via fax at 801-880-0699.